The FDA has removed indications that Niaspan and Trilipix should be used with statin cholesterol drugs and has also withdrawn approval for the marketing and sale of Advicor and Simcor…
Popular cholesterol drugs such as Lipitor and Crestor may increase the risk of developing cataracts, according to a new study.
Doctors frequently prescribe cholesterol-fighting drugs that may carry a risk of significant side effects, even though there is limited evidence that the drugs will help their patients, according to the…
Researchers indicate that despite an increased risk of acquiring type 2 diabetes from statin medications, such as Crestor and Lipitor, the benefits of the cholesterol-reducing drugs still outweigh any known…
Federal health regulators are warning that cholesterol lowering drugs like Lipitor, Crestor and Zocor could increase the risk of diabetes, muscle injury and could cause cognitive impairments like memory loss…
Federal regulators have signed off on a redesign for the labels of a number of Merck drugs, including Zocor, Propecia, Januvia and a dozen other drugs, to improve readability and…
The FDA did not go far enough in restricting the use of high doses of the cholesterol drug Zocor, and approval for 80 mg simvastatin medications should have been withdrawn…
Federal drug safety reviewers are calling for limits use of the highest dose of the cholesterol drug simvastatin, which is most commonly marketed as Zocor, saying that the 80 mg…
A number of different prescription medications have been linked to an increased risk of the serious and potentially fatal muscle condition known as rhabdomyolysis. As a result of a particularly…
High doses of the cholesterol-fighting drug Zocor can increase the risk of rhabdomyolysis, a serious and potentially fatal muscle disease, according to federal regulators.
